Skip to Content
ETF Specialist

The Best and Worst New ETPs of 2018

We take a look at the most promising and pitiful new exchange-traded products that were added to the menu in the past year.

Mentioned: , , , , , , , , ,

As of Dec. 19, there were 272 new exchange-traded products (inclusive of exchange-traded funds and exchange-traded notes) launched in the U.S. market in 2018. This placed fourth behind 2017, 2015, and 2011 in terms of the total number of new ETP launches in a calendar year. There are now 2,292 ETPs available to investors. Since  SPDR S&P 500 ETF (SPY) was launched in 1993, 3,113 ETPs have been brought to market. This means that about 26% of them have since been closed. [1]

Though there are plenty of choices on the ever-expanding menu, investors' tastes are basic. Of the 2,292 ETPs on offer, the top 100 as measured by assets under management accounted for 71% of the $3.4 trillion invested in ETPs at the middle of December. The top 100 are the Swiss Army knives of the ETP menu. They are efficient multipurpose tools that do a lot of different jobs for a lot of different people.

Ben Johnson does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.